Blue Sail Valuation

002382 Stock   5.14  0.07  1.34%   
At this time, the firm appears to be fairly valued. Blue Sail Medical shows a prevailing Real Value of USD5.14 per share. The current price of the firm is USD5.14. Our model approximates the value of Blue Sail Medical from analyzing the firm fundamentals such as Current Valuation of 6.63 B, return on equity of -0.0442, and Profit Margin of (0.07) % as well as examining its technical indicators and probability of bankruptcy.
Price Book
0.5859
Enterprise Value
6.6 B
Enterprise Value Ebitda
30.4252
Price Sales
0.8498
Enterprise Value Revenue
1.105
Fairly Valued
Today
5.14
Please note that Blue Sail's price fluctuation is somewhat reliable at this time. Calculation of the real value of Blue Sail Medical is based on 3 months time horizon. Increasing Blue Sail's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Blue Sail is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Blue Stock. However, Blue Sail's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  5.14 Real  5.14 Hype  5.14 Naive  5.12
The real value of Blue Stock, also known as its intrinsic value, is the underlying worth of Blue Sail Medical Company, which is reflected in its stock price. It is based on Blue Sail's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Blue Sail's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
5.13
Real Value
7.00
Upside
Estimating the potential upside or downside of Blue Sail Medical helps investors to forecast how Blue stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Blue Sail more accurately as focusing exclusively on Blue Sail's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.000.000.00
Details
Hype
Prediction
LowEstimatedHigh
3.285.147.00
Details
Naive
Forecast
LowNext ValueHigh
3.265.126.99
Details

Blue Sail Cash

1.04 Billion

Blue Sail Total Value Analysis

Blue Sail Medical is presently forecasted to have takeover price of 6.63 B with market capitalization of 5.1 B, debt of 3.86 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Blue Sail fundamentals before making investing decisions based on enterprise value of the company

Blue Sail Investor Information

About 33.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 0.59. In the past many companies with similar price-to-book ratios have beat the market. Blue Sail Medical recorded a loss per share of 0.44. The entity last dividend was issued on the 31st of May 2023. The firm had 20:10 split on the 17th of May 2016. Blue Sail Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

Blue Sail Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Blue Sail has an asset utilization ratio of 31.52 percent. This suggests that the Company is making USD0.32 for each dollar of assets. An increasing asset utilization means that Blue Sail Medical is more efficient with each dollar of assets it utilizes for everyday operations.
 
Credit Downgrade
 
Yuan Drop
 
Covid

Blue Sail Ownership Allocation

Blue Sail holds a total of 1.01 Billion outstanding shares. Blue Sail Medical retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Blue Sail Profitability Analysis

The company reported the revenue of 4.93 B. Net Loss for the year was (568.36 M) with profit before overhead, payroll, taxes, and interest of 857.27 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Blue Sail's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Blue Sail and how it compares across the competition.

About Blue Sail Valuation

The stock valuation mechanism determines Blue Sail's current worth on a weekly basis. Our valuation model uses a comparative analysis of Blue Sail. We calculate exposure to Blue Sail's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Blue Sail's related companies.
Last ReportedProjected for Next Year
Gross Profit697 M662.1 M

Blue Sail Quarterly Retained Earnings

1.9 Billion

Complementary Tools for Blue Stock analysis

When running Blue Sail's price analysis, check to measure Blue Sail's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Blue Sail is operating at the current time. Most of Blue Sail's value examination focuses on studying past and present price action to predict the probability of Blue Sail's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Blue Sail's price. Additionally, you may evaluate how the addition of Blue Sail to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities